ImmuneBiotech Medical Sweden AB Strengthens Leadership with the Appointment of Rickard Mosell as Chairman of the Board

ImmuneBiotech AB

ImmuneBiotech AB, a pioneering probiotic and microbiome company, is pleased to announce the appointment of life science veteran Rickard Mosell as its new Chairman of the Board. This pivotal recruitment marks a major milestone in the companys growth strategy, reinforcing its leadership team.

 We are thrilled to welcome Rickard as our new Chairman of the Board. His extensive expertise in scaling life science businesses and his vast network within the industry and academia will be instrumental as we continue to drive our growth and expand our product offerings. says Shahram Lavasani, founder and CEO of ImmuneBiotech.

Mr. Mosells appointment reflects ImmuneBiotechs ongoing commitment to enhancing its strategic capabilities and reinforcing its leadership in the rapidly growing probiotics and microbiome sectors. His insights will support the companys mission to deliver scientifically-backed, high-quality products that improve the lives of customers around the world.

Rickard Mosell has over 20 years of experience in leading organizations within the Swedish innovation ecosystem. He has co-founded two companies and built an extensive network. He has held prominent roles such as senior advisor at LU Holding, chairman and advisor at the incubator Ideon Innovation, CEO of Ideon Science Park, and represented Sweden as a Wallenberg Fellow at Nordic Innovation House in Silicon Valley.

Welcome to the team, Rickard Mosell!